4//SEC Filing
ARIAD PHARMACEUTICALS INC 4
Accession 0001127602-15-012775
CIK 0000884731operating
Filed
Mar 29, 8:00 PM ET
Accepted
Mar 30, 4:21 PM ET
Size
19.5 KB
Accession
0001127602-15-012775
Insider Transaction Report
Form 4
BERGER HARVEY J M D
DirectorChairman & CEO
Transactions
- Exercise/Conversion
Common Stock
2015-03-26$7.56/sh+26,454$199,992→ 1,347,108 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2015-03-26−12,544→ 0 totalExercise: $7.56From: 2006-10-04Exp: 2015-10-04→ Common Stock (12,544 underlying) - Tax Payment
Common Stock
2015-03-26$8.17/sh−102,715$839,182→ 1,343,460 total - Exercise/Conversion
Common Stock
2015-03-26$7.56/sh+111,002$839,175→ 1,446,175 total - Tax Payment
Common Stock
2015-03-26$8.17/sh−24,479$199,993→ 1,322,629 total - Exercise/Conversion
Common Stock
2015-03-26$7.56/sh+12,544$94,833→ 1,335,173 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2015-03-26−26,454→ 0 totalExercise: $7.56From: 2006-10-04Exp: 2015-10-04→ Common Stock (26,454 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2015-03-26−111,002→ 0 totalExercise: $7.56From: 2006-10-04Exp: 2015-10-04→ Common Stock (111,002 underlying)
Holdings
- 246,054(indirect: Daughter)
Common Stock
- 1,864,286(indirect: By LLC)
Common Stock
- 245,251(indirect: By Spouse)
Common Stock
- 248,745(indirect: Daughter)
Common Stock
Footnotes (3)
- [F1]Shares were acquired upon the exercise of outstanding stock options at $7.56 per share.
- [F2]Represents shares withheld to pay for the exercise cost related to the exercise of outstanding options and to satisy withholding tax requirements.
- [F3]The reporting person is a managing member of this LLC.
Documents
Issuer
ARIAD PHARMACEUTICALS INC
CIK 0000884731
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000884731
Filing Metadata
- Form type
- 4
- Filed
- Mar 29, 8:00 PM ET
- Accepted
- Mar 30, 4:21 PM ET
- Size
- 19.5 KB